Profound Thrombocytopenia in Previously Treated Patients with Recurrent Ovarian Carcinoma Receiving Topotecan

By Cass I.   Kuo D.Y.   Fields A.L.   Runowicz C.D.   Goldberg G.L.  

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Patients with Recurrent Epithelial Ovarian Carcinoma

By Scarabelli C.   Gallo A.   Carbone A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 504-512

Elsevier

Access to resources Recommend Favorite

Evaluation of Recombinant Human Interleukin-12 in Patients with Recurrent or Refractory Ovarian Cancer: A Gynecologic Oncology Group Study

By Hurteau J.A.   Blessing J.A.   DeCesare S.L.   Creasman W.T.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 7-10

Elsevier

Access to resources Recommend Favorite

Impact of serum interleukin-18 level as a prognostic indicator in patients with epithelial ovarian carcinoma

By Akahira Jun-ichi   Konno Ryo   Ito Kiyoshi   Okamura Kunihiro   Yaegashi Nobuo  

International Journal of Clinical Oncology, Vol. 9, Iss. 1, 2004-02 ,pp. : 42-46

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

By Campos Susana  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite